Skip to content

Study on changes in blood glucose level by ingestion of dried banana powder

Study on changes in blood glucose level by ingestion of dried banana powder - Study on changes in blood glucose level by ingestion of dried banana powder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047748
Enrollment
60
Registered
2022-05-13
Start date
2022-05-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest test food A (25g dried banana powder) and carbohydrate tolerance foods on a single day for an acute trial and ingest test food A daily for 8 weeks for a chronic trial Ingest test food B (21.2g

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who provide written informed consent to participate in this study 2.Japanese men and women who are between 20 and 50 years old 3.Persons who have less than 126 mg/dL of fasting blood glucose 4.Persons who have no glucose intolerance within the past year (persons who have never been diagnosed or indicated as diabetes or pre-diabetes) 5.Persons who meet the above criteria with a fasting blood glucose level in the top 60

Exclusion criteria

Exclusion criteria: 1.Persons who have BMI of less than 18 kg/m2 or more than 30 kg/m2 2.Persons who have any chronic illnesses with medication and who have any serious disease histories 3.Persons who have any allergies to the ingredients used in the test food or dairy products 4.Persons who regularly take large amounts of the test food 5.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect blood glucose level 6.Persons who have participated in other tests within the past one month before the start of test, or those who intend to participate in another exam after consenting to the exam 7.Persons who were judged as inappropriate for study participant by the principal investigator 8.Persons who are breast-feeding, pregnant and planning or wishing to become pregnant during the study period

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose levels HbA1c

Secondary

MeasureTime frame
Postprandial blood glucose levels (delta AUC, delta Cmax, delta C, Tmax Fasting insulin levels Anthropometric measurements (body mass and BMI) Feelings of fullness (fullness, hunger, satisfaction, appetite score) Defecation condition (frequency, amount, stool form, smell, feeling of exhilaration)

Countries

Japan

Contacts

Public ContactYuki Asahina

Healthcare Systems Co., Ltd. Clinical Research Department

asahina.yuki@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026